Why screening?
Early prostate cancer causes no symptoms. Waiting for symptoms to appear gives away the best chance of cure. Screening aims to find tumours that need treatment while they are still confined to the prostate – and to avoid treating harmless findings unnecessarily.
The PSA test measures prostate-specific antigen in the blood. A raised value is a clue, not proof: benign enlargement, inflammation or cycling the day before can raise it too. The value is most useful as a trend and in combination with MRI and clinical judgement.
The Austrian Society of Urology recommends a check-up for men from age 45 – from 40 if there is prostate cancer in the family or a known BRCA mutation.